{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T23:33:51Z","timestamp":1771544031743,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T00:00:00Z","timestamp":1668038400000},"content-version":"vor","delay-in-days":709,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T00:00:00Z","timestamp":1599091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>The systemic autoinflammatory disorders (SAIDS) or periodic fever syndromes are disorders of innate immunity, which can be inherited or acquired. They are almost all very rare and easily overlooked; typically, patients will have seen multiple specialities prior to diagnosis, so a high level of clinical suspicion is key. It is important to note that these are \u2018high-value\u2019 diagnoses as the majority of these syndromes can be very effectively controlled, dramatically improving quality of life and providing protection against the development of irreversible complications such as AA amyloidosis. In Part 1 of this review, we took an overview of SAIDS and described the common features; in this article, we take a more in-depth look at the better recognized or more dermatologically relevant conditions.<\/jats:p>","DOI":"10.1111\/ced.14251","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T17:41:32Z","timestamp":1599154892000},"page":"967-973","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The systemic autoinflammatory disorders for dermatologists. Part 2: disease examples"],"prefix":"10.1093","volume":"45","author":[{"given":"J.","family":"Oldham","sequence":"first","affiliation":[{"name":"Portsmouth Hospitals NHS Trust National Amyloidosis Centre UCL Division of Medicine and Royal Free London NHS Foundation Trust Portsmouth Hampshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. J.","family":"Lachmann","sequence":"additional","affiliation":[{"name":"Portsmouth Hospitals NHS Trust National Amyloidosis Centre UCL Division of Medicine and Royal Free London NHS Foundation Trust Portsmouth Hampshire UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"2023041918365208900_ced14251-bib-0001","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.20082481","article-title":"In vivo regulation of interleukin 1beta in patients with cryopyrin-associated periodic syndromes","volume":"11","author":"Lachmann","year":"2009","journal-title":"J Exp Med"},{"key":"2023041918365208900_ced14251-bib-0002","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3389\/fimmu.2017.01410","article-title":"Late-onset cryopyrin-associated periodic syndromes caused by somatic NLRP3 mosaicism\u2014UK single center experience","volume":"8","author":"Rowczenio","year":"2017","journal-title":"Front Immunol"},{"key":"2023041918365208900_ced14251-bib-0003","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","article-title":"Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry","volume":"74","author":"Levy","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0004","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/MD.0b013e3181943f5e","article-title":"Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature","volume":"88","author":"Kieffer","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"2023041918365208900_ced14251-bib-0005","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.20033","article-title":"Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra","volume":"50","author":"Hawkins","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023041918365208900_ced14251-bib-0006","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/rheumatology\/kew208","article-title":"Long-term safety profile of anakinra in patients with severe cryopyrin-associated periodic syndromes","volume":"55","author":"Kullenberg","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2023041918365208900_ced14251-bib-0007","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2023041918365208900_ced14251-bib-0008","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","article-title":"Use of canakinumab in the cryopyrin-associated periodic syndrome","volume":"360","author":"Lachmann","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041918365208900_ced14251-bib-0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng0997-25","article-title":"A candidate gene for familial Mediterranean fever","volume":"17","author":"French FMF Consortium","year":"1997","journal-title":"Nat Genet"},{"key":"2023041918365208900_ced14251-bib-0010","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/annrheumdis-2012-202580","article-title":"MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease","volume":"73","author":"Stoffels","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0011","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat Immunol"},{"key":"2023041918365208900_ced14251-bib-0012","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1093\/rheumatology\/kei279","article-title":"Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations","volume":"45","author":"Lachmann","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"2023041918365208900_ced14251-bib-0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000152370.84628.0c","article-title":"Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study","volume":"84","author":"Tunca","year":"2005","journal-title":"Medicine"},{"key":"2023041918365208900_ced14251-bib-0014","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/annrheumdis-2012-202932","article-title":"Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents","volume":"73","author":"Twig","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0015","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0016","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2023041918365208900_ced14251-bib-0017","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00109-014-1150-5","article-title":"Tumor necrosis factor receptor-associated periodic syndrome as a model linking autophagy and inflammation in protein aggregation diseases","volume":"92","author":"Bachetti","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"2023041918365208900_ced14251-bib-0018","first-page":"2035","article-title":"The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever\/EUROTRAPS international registry","volume":"71","author":"Lachmann","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0019","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/art.37827","article-title":"AA amyloidosis complicating the hereditary periodic fever syndromes","volume":"65","author":"Lane","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2023041918365208900_ced14251-bib-0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0021","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"De Benedetti","year":"2018","journal-title":"N Engl J Med"},{"key":"2023041918365208900_ced14251-bib-0022","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.jaci.2017.02.033","article-title":"Defective protein prenylation is a diagnostic biomarker of mevalonate kinase deficiency","volume":"140","author":"Munoz","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"2023041918365208900_ced14251-bib-0023","doi-asserted-by":"crossref","first-page":"27757","DOI":"10.1074\/jbc.M114.571810","article-title":"Unprenylated RhoA contributes to IL-1\u03b2 hypersecretion in mevalonate kinase deficiency model through stimulation of Rac1 activity","volume":"289","author":"Burgh","year":"2014","journal-title":"J Biol Chem"},{"key":"2023041918365208900_ced14251-bib-0024","first-page":"821","article-title":"The phenotype and genotype of mevalonate kinase deficiency: a series of 114 cases from the Eurofever registry","volume":"68","author":"Ter Haar","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"Suppl","key":"2023041918365208900_ced14251-bib-0025","first-page":"S46","article-title":"Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature","volume":"33","author":"Lane","year":"2015","journal-title":"Clin Exp Rheum"},{"key":"2023041918365208900_ced14251-bib-0026","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/all.12129","article-title":"Schnitzler's syndrome: diagnosis, treatment, and follow-up","volume":"68","author":"Simon","year":"2013","journal-title":"Allergy"},{"key":"2023041918365208900_ced14251-bib-0027","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1172-5-38","article-title":"The Schnitzler syndrome","volume":"5","author":"Lipsker","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"2023041918365208900_ced14251-bib-0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.semarthrit.2007.04.001","article-title":"Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment","volume":"37","author":"Koning","year":"2007","journal-title":"Semin Arthritis Rheum"},{"key":"2023041918365208900_ced14251-bib-0029","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2012.02843.x","article-title":"Efficacy and safety of the interleukin-1 antagonist rilonacept in Schnitzler syndrome: an open-label study","volume":"67","author":"Krause","year":"2012","journal-title":"Allergy"},{"key":"2023041918365208900_ced14251-bib-0030","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jaci.2011.05.023","article-title":"Successful canakinumab treatment identifies IL-1beta as a pivotal mediator in Schnitzler syndrome","volume":"128","author":"Koning","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"2023041918365208900_ced14251-bib-0031","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.2005.045245","article-title":"Beneficial response to anakinra and thalidomide in Schnitzler's syndrome","volume":"65","author":"Koning","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"2023041918365208900_ced14251-bib-0032","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1056\/NEJMoa0807865","article-title":"An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist","volume":"360","author":"Aksentijevich","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041918365208900_ced14251-bib-0033","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1056\/NEJMoa0809568","article-title":"An autoinflammatory disease due to homozygous deletion of the IL1RN locus","volume":"360","author":"Reddy","year":"2009","journal-title":"N Engl J Med"},{"key":"2023041918365208900_ced14251-bib-0034","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/humu.22203","article-title":"Mutation analysis of the IL36RN gene in 14 Japanese patients with generalized pustular psoriasis","volume":"34","author":"Farooq","year":"2013","journal-title":"Hum Mutat"},{"key":"2023041918365208900_ced14251-bib-0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N Engl J Med"},{"key":"2023041918365208900_ced14251-bib-0036","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.ajhg.2011.07.022","article-title":"Mutations in IL36RN\/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis","volume":"89","author":"Onoufriadis","year":"2011","journal-title":"Am J Hum Genet"},{"key":"2023041918365208900_ced14251-bib-0037","doi-asserted-by":"crossref","first-page":"e1043","DOI":"10.1542\/peds.2012-3935","article-title":"First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra","volume":"132","author":"Rossi-Semerano","year":"2013","journal-title":"Pediatrics"}],"updated-by":[{"DOI":"10.1111\/ced.14542","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,22]],"date-time":"2021-03-22T00:00:00Z","timestamp":1616371200000}}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ced.14251","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ced.14251","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/45\/8\/967\/50034855\/ced0967.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/45\/8\/967\/50034855\/ced0967.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T18:39:43Z","timestamp":1681929583000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/45\/8\/967\/6597914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":37,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,12,1]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/ced.14251","relation":{"erratum":[{"id-type":"doi","id":"10.1111\/ced.14542","asserted-by":"object"}]},"ISSN":["1365-2230","0307-6938"],"issn-type":[{"value":"1365-2230","type":"electronic"},{"value":"0307-6938","type":"print"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}